Clinical trial
Study of Cancer Stem Cell Vaccine That as a Specific Antigen in Metastatic of the Nasopharynx
NCT02115958 is registered in ClinicalTrials.gov with Fuda Cancer Hospital, Guangzhou as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of Cancer Stem Cell Vaccine That as a Specific Antigen in Metastatic of the Nasopharynx
- Lead sponsor
- Fuda Cancer Hospital, Guangzhou
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- March 31, 2014
- Completion date
- May 31, 2015
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
neoplasms, lung